Authors


Courtney Skriptshak, PharmD

Latest:

Cannabidiol Presents Conundrums

Recent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.


Amelia L. Persico, Pharm D, MBA

Latest:

Toxicity Is a Risk of PAMORA Interactions

Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.


Zil-e-Huma Sabir, PharmD Candidate

Latest:

Which Left Ventricular Assist Device Is Best?

Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.


Tonja M. Woods, PharmD

Latest:

10 Strategies for Minimizing Dispensing Errors

Dispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.


Eric Balotin, RPh

Latest:

A Collaborative Approach to Specialty Pharmacy at an Academic Medical Center

The SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.



Hua Li, MD, PhD

Latest:

Healthcare Utilization and Costs for Insured Patients With Fibromyalgia

Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.


Sara Valanejad, PharmD Candidate

Latest:

The Benefit of Dual Degree Programs

As a student pharmacist, it can be difficult to keep up with the fast-paced changes of the pharmacy profession. As the pharmacy profession continues to expand, we must continue to challenge ourselves by advancing our education and training.



Burt Zweigenhaft

Latest:

The Pharmaceutical Ecosystem Must Work Together to Provide Sustainable Innovation and Ensure Patient Access

Growth in the use of specialty drugs demands the evolution of patient care models that leverage the knowledge of all relevant stakeholders. 



Mary Caffrey

Latest:

End of OCM Brings Drop-Off in Value-Based Care Volume, New Questions

Questions arise around equity and revenue challenges.


Jon C. Montague-Clouse, BS, MS

Latest:

Outcomes of a Specialty Pharmacy Program for Oral Oncology Medications

Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.


Elizabeth L. Eby, MPH

Latest:

Do Units and Costs of Comparable Insulins Differ by Manufacturer?

Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.


Wendy Weingart, RPh

Latest:

340B Drug Discount Program in the Cross Hairs

The drug industry wants to shrink the 340B drug discount program; however, safety net providers insist it is vital to treating the poor.


Ashley Dolphus, PharmD

Latest:

The Community Pharmacist Role in Antiemetic Therapy for Outpatient Chemotherapy Treatment

Despite improvements in the understanding and treatment of chemotherapy-induced nausea and vomiting (CINV), nausea and emesis continue to be a distressing adverse event for patients.


Osayi E. Akinbosoye, PhD, PAHM

Latest:

Factors Associated with Zostavax Abandonment

This study highlights the implications of noncompliance with the use of in-network providers for immunization services, shedding light on value-based benefits design to promote access to recommended vaccinations.


Raymond Tran, PharmD Candidate

Latest:

Case Studies (October 2017)

What should these pharmacists do?


Matthew Bailey, PharmD Candidate

Latest:

What Are the Newest Breast Cancer Treatment Options?

Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results


Alexandra M. San Roman, BA

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Elizabeth B. Hirsch, PharmD, RPh

Latest:

New Antibiotics Treat Select Resistant Infections

Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.


Renee Michelle Striker, PharmD

Latest:

Bipolar Disorder: Treating Both Ends of the Spectrum

At the time of writing, Dr. Striker was a psychiatry pharmacy resident at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center (VAMC), a pharmacist at Huron Hospital, and a relief pharmacist with Target Pharmacy. Dr. Fuller is a clinical pharmacy specialist in psychiatry at the Louis Stokes Cleveland VAMC, a clinical pharmacy specialist in psychiatry with Lexi-Comp Inc, an associate clinical professor of psychiatry at Case Western Reserve University, and an adjunct associate professor of clinical pharmacy at the University of Toledo.


Shien Guo, PhD

Latest:

Persistence With Antiarrhythmics and the Impact on Atrial Fibrillation–Related Outcomes

Retrospective analysis of claims data showed that persistence with amiodarone and sotalol was generally poor.


Wenyi Wang, MS

Latest:

Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid Arthritis

For patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.



William W. Wood, RPh

Latest:

340B Drug Discount Program in the Cross Hairs

The drug industry wants to shrink the 340B drug discount program; however, safety net providers insist it is vital to treating the poor.


Laurie Saloman, MS

Latest:

Study: PrEP Remains Effective Regardless of Sexual Activity Frequency

Dosing based around the frequency of sexual activity provides adequate protection for men vulnerable to HIV infection.



Jennifer Chan Marcelo, PharmD, BCACP

Latest:

Evaluating Allergic Rhinitis in the Convenient Health Care Clinic: Treatment Strategies for Clinicians and Pharmacists

This Continuing Education activity is supported by an educational grant from McNeil Consumer Healthcare Division.


Christen Ferguson, PharmD candidate

Latest:

Leukemia: Causes, Symptoms, and Treatments

Leukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.